How Does Liraglutide Compare to Laser Acupuncture for Weight Loss? A 745-Patient Study

In a retrospective comparison of 745 patients, laser acupuncture users lost more weight than liraglutide users over 180 days, though the study design has significant limitations.

Yu, Wen-Lin et al.·Healthcare (Basel·2024·Moderate Evidencecohort
RPEP-09615CohortModerate Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
cohort
Evidence
Moderate Evidence
Sample
N=not reported
Participants
Obese patients from the Chang Gung Research Database (2013-2018)

What This Study Found

Laser acupuncture users lost an average of 5.82 kg versus 2.38 kg with liraglutide over 180 days, with the difference remaining significant after adjusting for baseline differences.

Key Numbers

Data from 2013-2018 analyzed with primary outcomes measured at 180 days post-treatment.

How They Did This

Multi-institutional retrospective cohort study using the Chang Gung Research Database (2013-2018). Compared 173 laser acupuncture users with 572 liraglutide users. Primary outcomes: body weight and BMI changes at 180 days. Secondary outcomes: proportion achieving 5%, 10%, and 15% weight loss. Statistical adjustments made for baseline differences.

Why This Research Matters

GLP-1 receptor agonists like liraglutide are widely used for weight management, but not all patients respond well or tolerate side effects. Understanding how these peptide drugs compare to alternative approaches helps inform treatment decisions.

The Bigger Picture

While GLP-1 peptide drugs dominate the weight loss landscape, this study raises questions about comparative effectiveness with non-pharmacological approaches. However, the retrospective design and self-selection bias mean these results should be interpreted cautiously — randomized controlled trials are needed to make fair comparisons.

What This Study Doesn't Tell Us

Retrospective design with significant self-selection bias — patients choosing acupuncture versus medication likely differ in motivation, lifestyle, and other factors. No randomization or blinding. Database study lacks detailed clinical context such as diet, exercise, and compliance. Liraglutide dosing details not specified. The liraglutide doses used (2013-2018) may not reflect current optimal protocols.

Questions This Raises

  • ?Would a randomized controlled trial confirm laser acupuncture superiority over liraglutide for weight loss?
  • ?Could combining laser acupuncture with GLP-1 peptide drugs produce better results than either alone?
  • ?How do these results compare with newer, more potent GLP-1 drugs like semaglutide or tirzepatide?

Trust & Context

Key Stat:
5.82 vs 2.38 kg weight loss at 180 days for laser acupuncture versus liraglutide users, though self-selection bias limits interpretation
Evidence Grade:
Moderate evidence: large multi-institutional cohort with statistical adjustments, but retrospective design with significant self-selection bias prevents causal conclusions.
Study Age:
Published in 2024, but uses data from 2013-2018 — predating newer GLP-1 drugs and optimized dosing protocols.
Original Title:
Laser Acupuncture versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study.
Published In:
Healthcare (Basel, Switzerland), 12(13) (2024)
Database ID:
RPEP-09615

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Does this mean liraglutide does not work for weight loss?

No. Liraglutide has been proven effective in multiple randomized controlled trials. This retrospective study has significant limitations — patients who chose acupuncture may have been more motivated or different in ways that affected outcomes.

Should I try laser acupuncture instead of GLP-1 peptides?

This single retrospective study is not sufficient to guide treatment decisions. GLP-1 drugs have far more robust evidence from randomized trials. Discuss all options with your healthcare provider.

Read More on RethinkPeptides

Cite This Study

RPEP-09615·https://rethinkpeptides.com/research/RPEP-09615

APA

Yu, Wen-Lin; Liao, Yu-Ning; Yang, Tsung-Hsien; Yang, Ching-Wei; Kao, Ting-I; Lee, Pai-Wei; Hsu, Chiu-Yi; Huang, Jhen-Ling; Huang, Yu-Tung; Chen, Hsing-Yu. (2024). Laser Acupuncture versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study.. Healthcare (Basel, Switzerland), 12(13). https://doi.org/10.3390/healthcare12131279

MLA

Yu, Wen-Lin, et al. "Laser Acupuncture versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study.." Healthcare (Basel, 2024. https://doi.org/10.3390/healthcare12131279

RethinkPeptides

RethinkPeptides Research Database. "Laser Acupuncture versus Liraglutide in Treatment of Obesity..." RPEP-09615. Retrieved from https://rethinkpeptides.com/research/yu-2024-laser-acupuncture-versus-liraglutide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.